Adaptive Biotechnologies Corp ($ADPT)
Filing Information
| Accession Number | 0001780664-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 14, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
268,035
Total Value
$2,663,345.41
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and COO | Common Stock | โ | Mar 11, 2026 | Sale | 122,523 | $13.17 | $1,613,627.91 | 520,948 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 11, 2026 | Exercise/Conversion | 14,722 | $6.55 | $96,429.10 | 535,670 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 11, 2026 | Sale | 19,060 | $14.08 | $268,364.80 | 516,610 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 12, 2026 | Exercise/Conversion | 14,722 | $6.55 | $96,429.10 | 531,332 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 12, 2026 | Sale | 13,660 | $12.63 | $172,525.80 | 517,672 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 12, 2026 | Sale | 5,400 | $13.43 | $72,522.00 | 512,272 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 13, 2026 | Exercise/Conversion | 14,722 | $6.55 | $96,429.10 | 526,994 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 13, 2026 | Sale | 19,060 | $12.96 | $247,017.60 | 507,934 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Mar 11, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 92,271 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Mar 12, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 77,549 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Mar 13, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 62,827 | Direct | โ | View Details |